Alumis to Participate in Upcoming September Investor Conferences

About this update from Alumis Inc.

[{"type":"image","alt":"Alumis Inc.","displaySize":"","headline":null,"caption":"Alumis Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":150,"height":39,"url":"https://media.zenfs.com/en/globenewswire.com/cd047612371c6f86746cf01631a6f911"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/D1V_aGoKejvy_01T3BfhbQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTU1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/cd047612371c6f86746cf01631a6f911","width":150,"height":39}},"lazy":false},{"type":"text","content":"SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences:","length":300,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Cantor Global Healthcare Conference 2025 in New York, NY on September 3 at 9:45 am ET (fireside chat);","length":102,"tagName":"p"}]},{"val":[{"type":"text","content":"Wells Fargo 2025 Healthcare Conference in Boston, MA on September 5 at 9:30 am ET (fireside chat);","length":103,"tagName":"p"}]},{"val":[{"type":"text","content":"Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY on September 8 at 4:50 pm ET (fireside chat);","length":122,"tagName":"p"}]},{"val":[{"type":"text","content":"H.C. Wainwright 27th Annual Global Investment Conference in New York, NY on September 9 at 10:30 am ET (presentation);","length":123,"tagName":"p"}]},{"val":[{"type":"text","content":"Baird 2025 Global Healthcare Conference in New York, NY on September 10 at 2:35 pm ET (presentation); and","length":110,"tagName":"p"}]},{"val":[{"type":"text","content":"Stifel 2025 Virtual Immunology & Inflammation Forum on September 16 at 12:30 pm ET (virtual presentation)","length":114,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":674,"olType":false},{"type":"text","content":"To access available live webcasts please visit the “Events” page of the “Investors" section of the Alumis website. Webcast replays will be archived on the company's website for 90 days.","length":194,"tagName":"p"},{"type":"text","content":"About Alumis Alumis is a late-stage biopharma company developing next-generation targeted the...

More updates from Alumis Inc.